www.Top100Medicine.com - TOP 100 MEDICAL SITES
TOP 100 MEDICAL SITES
 Main  |  Add a Site  |  FREE Content for Your Web-site  |  Bookmark this site  |  Links  |  Webmaster 
Updated Sun, February 1, 2009.
1.www.galenicom.com2010000
2.www.aerzteblatt.de1310000
3.bmj.bmjjournals.com1060000
4.www.pubmedcentral.nih.gov800000
5.www.medicalnewstoday.com547000
6.www.med1.de522000
7.www.emedicine.com481000
8.www.obesityhelp.com393000
9.content.nejm.org371000
10.www.redcross.org343000
11.www.hospital-data.com316000
12.www.medi-learn.de292000
13.www.mdconsult.com285000
14.jama.ama-assn.org282000
15.www.med.univ-rennes1.fr260000
16.www.locateadoc.com250000
17.www.cpsc.gov243000
18.www.nih.gov234000
19.www.med.umich.edu229000
20.www.chestjournal.org226000
21.www.aafp.org215000
22.www.med.nyu.edu204000
23.www.aap.org202000
24.www.aerztlichepraxis.de199000
25.www.medscape.com188000
26.www.aerztestellen.de177000
27.www.gsm.com176000
28.www.efisioterapia.net176000
29.www.ahrq.gov174000
30.www.netdoktor.de164000
31.www.docguide.com161000
32.www.jneurosci.org156000
33.www.emedicinehealth.com155000
34.www.orpha.net154000
35.www.pfizer.com136000
36.www.ninds.nih.gov135000
37.www.gsk.com135000
38.www.medizin-forum.de131000
39.www.e-carabin.net130000
40.www.thieme.de129000
41.www.socialsecurity.gov128000
42.www.valuemd.com125000
43.www.meddean.luc.edu123000
44.www.baua.de122000
45.www.guideline.gov117000
46.ajp.psychiatryonline.org110000
47.www.urmc.rochester.edu107000
48.www.vh.org106000
49.www.obgyn.net102000
50.www.annals.org97700
Pages:  1  2  3  4  5  6  7  8  9  10  11  12 
 13  14  15  16 
Subscribe to RSS feed Subscribe to Feed Burner feed Add to Del.icio.us Add to Yahoo Add to Google Add to Furl Add to Reddit Add to Blink Add to Meneame Add to Fark Add to Ma.gnolia Add to Newsvine Add to Shadows

28. www.efisioterapia.net

Rating: 176000 points*
*amount mentions of word 'www.efisioterapia.net' on the other websites

www.efisioterapia.net

e Fisioterapia - articulos, enlaces, foros, clinicas, libros,cursos

Most popular searches: www.efisioterapi.net, wwwefisioterapia.net, Krankenhaus, www.efisioterpia.net, www.efisioteraia.net, www.efisioterapia.et, www.eisioterapia.net, www.fisioterapia.net, health care, Nachrichten, medical information, physician, www.efisioerapia.net, health, medical research, drug rehab, asthma, www.efisiterapia.net, vaccines, wwwefisioterapia.net, genome, Pharmaceutical, cholesterol, www.efisioterapia.nt, www.efisioterapia.com, ww.efisioterapia.net, obesity, ww.efisioterapia.net, www.efisioteapia.net, family practice, medicine, doctor, Allergy, www.efiioterapia.net, www.efsioterapia.net, Cardiac, blood pressure, patient, drug, Immunology, www.efisioterapia.ne, www.efisioterapa.net, www.efisioterapianet, www.efisoterapia.net, www.efisiotrapia.net, www.efisioterapia.net

Google

© 2005-2008 www.Top100Medicine.com
Cleveland BioLabs inks Chinese deal
A Buffalo biotech firm has signed a $1.65 million licensing agreement with a Chinese pharmaceutical manufacturer. (CBLI)
feeds.bizjournals.com		 Continuing to Accumulate Peregrine Pharma at Current Levels
VFC submits: On Monday Peregrine Pharmaceuticals issued a press release announcing Positive Results From the company's Phase II Bavituximab Lung Cancer Trial. A full copy of the press release is here. The PR had little, if any, influence on the stock price.I started accumulating shares of this company earlier this year based on the potential of Peregrine's two leading clinical products - Cotara and Bavituximab - which are currently being investigated for effectiveness in Phase II trials to treat various cancer and infectious disease indications.Complete Story »
seekingalpha.com		 Gen-probe Q3 2009 Earnings Call Transcript
Gen-probe, Inc. ( GPRO)Q3 2009 Earnings CallOctober 29, 2009 4:30 AM ETComplete Story »
seekingalpha.com		 Array BioPharma Announces Positive Interim Results for Phase 1 Study of Its HER2 Inhibitor, ARRY-380, in Cancer Patients (Business Wire)
BOULDER, Colo.----Array BioPharma Inc. today announced positive interim results of its novel, small molecule HER2 inhibitor, ARRY-380, in a Phase 1 trial in advanced cancer patients.
us.rd.yahoo.com		 Quest Diagnostics 4Q profit up even on volume down (AP)
Medical laboratory operator Quest Diagnostics Inc. said Monday its profit grew 7 percent in the fourth quarter due to greater use of genetic and specialized tests.
us.rd.yahoo.com